Role of Surgery in the Management for Gastric Cancer with Synchronous Distant Metastases

详细信息    查看全文

• 作者：Masahide Ikeguchi ; Kozo Miyatani ; Seigo Takaya…
• 关键词：Gastric cancer ; Gastrectomy ; Synchronous distant metastasis ; Survival
• 刊名：Indian Journal of Surgical Oncology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：7
• 期：1
• 页码：32-36
• 全文大小：283 KB
• 参考文献：1.Sugarbaker PH, Yonemura Y (2001) Palliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology 48:1238–1247PubMed
  2.Lim S, Muhs BE, Marcus SG, Newman E, Berman RS, Hiotis SP (2007) Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups? J Surg Oncol 95:118–122CrossRef PubMed
  3.Lin SZ, Tong HF, You T, Yu YJ, Wu WJ, Chen C, Zhang W, Ye B, Li CM, Zhen ZQ, Xu JR, Zhou JL (2008) Palliative gastrectomy and chemotherapy for stage IV gastric cancer. J Cancer Res Clin Oncol 134:187–192CrossRef PubMed
  4.Yagi Y, Seshimo A, Kameoka S (2000) Prognostic factors in stage IV gastric cancer: univariate and multivariate analyses. Gastric Cancer 3:71–80CrossRef PubMed
  5.Monson JR, Donohue JH, McIlrath DC, Farnell MB, Ilstrup DM (1991) Total gastrectomy for advanced cancer. A worthwhile non-curative procedure. Cancer 68:1863–1868CrossRef PubMed
  6.McCarter MD, Fong Y (2001) Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol 8:38–43CrossRef PubMed
  7.Saidi RF, ReMine SG, Dudrick PS, Hanna NN (2006) Is there a role for non-curative gastrectomy in patients with stage IV gastric cancer? World J Surg 30:21–27CrossRef PubMed
  8.Hartgrink HH, Putter H, Klein Kranenbarg E, Bonenkamp JJ, van de Velde CJ, Dutch Gastric Cancer Group (2002) Value of non-curative resection in gastric cancer. Br J Surg 89:1438–1443CrossRef PubMed
  9.Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112. doi:10.​1007/​s10120-011-0041-5 CrossRef
  10.Buccheri G, Ferrigno D, Tamburini M, Karnofsky and ECOG performance status scoring in lung cancer (1996) A prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 32A:1135–1141CrossRef PubMed
  11.Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, Tsujitani S, Seto Y, Furukawa H, Oda I, Ono H, Tanabe S, Kaminishi M (2013) Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer 16:1–27. doi:10.​1007/​s10120-012-0163-4 CrossRef PubMed PubMedCentral
  12.Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, Kokudo N, Yamaguchi T, Muto T, Makuuchi M (2003) Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 133:507–511CrossRef PubMed
  13.Tokunaga M, Ohyama S, Hiki N, Fukunaga T, Aikou S, Yamaguchi T (2010) Can super extended lymph node dissection be justified for gastric cancer with pathologically positive para-aortic lymph nodes? Ann Surg Oncol 17:2031–2036. doi:10.​1245/​s10434-010-0969-4 CrossRef PubMed
  14.Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, Miyashita K, Nishizaki T, Kobayashi O, Takiyama W, Toh Y, Nagaie T, Takagi S, Yamamura Y, Yanaoka K, Orita H, Takeuchi M (2008) S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol 9:215–221. doi:10.​1016/​S1470-2045(08)70035-4 CrossRef PubMed
  15.Samarasam I, Chandran BS, Sitaram V, Perakath B, Nair A, Mathew G (2006) Palliative gastrectomy in advanced gastric cancer: is it worthwhile? ANZ J Surg 76(1–2):60–63CrossRef PubMed
  16.Ouchi K, Sugawara T, Ono H, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J, Yamanami H (1998) Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 69:41–44CrossRef PubMed
  17.Chen S, Li YF, Feng XY, Zhou ZW, Yuan XH, Chen YB (2012) Significance of palliative gastrectomy for late-stage gastric cancer patients. J Surg Oncol 106:862–871. doi:10.​1002/​jso.​23158 CrossRef PubMed
  18.Tokunaga M, Terashima M, Tanizawa Y, Bando E, Kawamura T, Yasui H, Boku N (2012) Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis. World J Surg 36:2637–2643. doi:10.​1007/​s00268-012-1721-y CrossRef PubMed
  19.Tsuchida K, Yoshikawa T, Tsuburaya A, Cho H, Kobayashi O (2011) Indications for staging laparoscopy in clinical T4M0 gastric cancer. World J Surg 35:2703–2709. doi:10.​1007/​s00268-011-1290-5 CrossRef PubMed
  20.Oñate-Ocaña LF, Méndez-Cruz G, Hwrnández-Ramos R, Becker M, Carrillo JF, Herrera-Goepfert R, Aiello-Crocifoglio V, Ochoa-Carrillo F, Beltrán-Ortega A (2007) Experience of surgical morbidity after palliative surgery in patients with gastric carcinoma. Gastric Cancer 10:215–220CrossRef PubMed
  21.Fujitani K, Yang HK, Kurokawa Y, do Park J, Tsujinaka T, Park BJ, Fukuda H, Noh SH, Boku N, Bang YJ, Sasako M, Lee JI, Gastric Cancer Surgical Study Group of Japan Clinical Oncology Group, Korea Gastric Cancer Association (2008) Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. Jpn J Clin Oncol 38:504–506. doi:10.​1093/​jjco/​hyn058 CrossRef PubMed
  22.Keränen I, Kylänpää L, Udd M, Louhimo J, Lepistö A, Halttunen J, Kokkola A (2013) Gastric outlet obstruction in gastric cancer: a comparison of three palliative methods. J Surg Oncol 108:537–541. doi:10.​1002/​jso.​23442 CrossRef PubMed
  
• 作者单位：Masahide Ikeguchi (1)
  Kozo Miyatani (1)
  Seigo Takaya (1)
  Tomoyuki Matsunaga (1)
  Youji Fukumoto (1)
  Tomohiro Osaki (1)
  Hiroaki Saito (1)
  Toshiro Wakatsuki (1)
  
  1. Department of Surgery, Division of Surgical Oncology, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, 683-8504, Japan
  
• 刊物主题：Surgical Oncology; Oncology; Surgery;
• 出版者：Springer India
• ISSN：0976-6952

文摘

Optimal treatment of patients with gastric cancer with synchronous distant metastases is palliative chemotherapy. However, occasionally gastrectomy should be selected due to control bleeding from tumors, perforation, or obstruction. The aim of this study is to evaluate the survival benefits of non-curative gastrectomy for patients with synchronous distant metastasis. Total 78 gastric cancer patients with synchronous distant metastasis treated in our hospital between 2003 and 2012 were enrolled in this study. Of these, 74 patients (95 %) received S1 based chemotherapy. During the treatment, 37 patients (47.4 %) underwent palliative gastrectomy because of bleeding from tumors (n = 15), tumor perforation (n = 6), and obstruction (n = 16). Survival benefits were compared in resected and non-resected patients, retrospectively. The two groups were clinicopathologically similar. Palliative gastrectomy was performed safely (morbidity: 10.8 % and mortality: 0) in resection group. However, resection showed survival benefits only in 13 patients (16.7 %) with single metastasis and without peritoneal metastasis. Their 2-year survival rate was 40 % and their median survival was 19 months. Non-curative gastrectomy with precise surgical techniques followed careful postoperative nutrition management may improve survival only for patients with a single metastatic site, except for peritoneal dissemination.